These reports are in line with our results, which presented the elevated fibronectin levels in circulating CD14+ monocytes and CD14+ pulmonary macrophages in SSc patients and highlighted the capability of CD14+ monocytes to acquire a profibrotic phenotype. This evidence concerns the gene CD14 and systemic sclerosis.